Home > Riviste > Minerva Pediatrica > Fascicoli precedenti > Articles online first > Minerva Pediatrica 2015 Nov 25

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti
Per citare questo articolo

MINERVA PEDIATRICA

Rivista di Pediatria, Neonatologia, Medicina dell’Adolescenza
e Neuropsichiatria Infantile


Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,764


eTOC

 

Minerva Pediatrica 2015 Nov 25

Copyright © 2015 EDIZIONI MINERVA MEDICA

lingua: Inglese

Allergen immunotherapy and respiratory infections in children: an encouraging experience

Barberi S. 1, Bernardo L. 1, D’Auria E. 2, Ferrara F. 1, Tosi S. 1, Incorvaia C. 3, Buttafava S. 4, Frati F. 4, Ciprandi G. 5

1 Department of Pediatrics, Fatebenefratelli Hospital, Milan, Italy; 2 Department of Pediatrics, San Paolo Hospital, Milan, Italy; 3 Allergy/Pulmonary Rehabilitation, ICP Hospital, Milan, Italy; 4 Medical and Scientific Department, Stallergenes Italy, Milan, Italy; 5 Department of Medicine, IRCCS-Azienda Ospedaliera Universitaria San Martino, Genoa, Italy


PDF  


AIM: Allergic inflammation may promote respiratory infections (RI). House dust mite (HDM) sensitization is common in childhood. Allergen immunotherapy may cure allergy as it restores a physiological immune and clinical tolerance toward the causal allergen and exerts anti- inflammatory activity. This study retrospectively investigated whether 3 year high-dose HDM- sublingual immunotherapy (SLIT) could affect respiratory infections in children with allergic rhinitis.
METHODS: Globally, 33 HDM allergic children (18 males, mean age 9.3 years) were subdivided in 2 groups: 20 treated with symptomatic drugs alone (Group 1) and 13 by high-dose SLIT, titrated in mcg of major allergens (Group 2) for 3 years.
RESULTS: SLIT-treated children had significantly (p=0.01) less RI episodes (3.6) than symptomatically-treated children (5.4). In addition, SLIT-treated children had less fever (p<0.01) and took fewer medications, such as antibiotics (p<0.05) and fever-reducers (p<0.01), than symptomatically-treated children.
CONCLUSION: This preliminary study suggests that high-dose 3-year SLIT might lessen RI in allergic children.

inizio pagina

Publication History

Per citare questo articolo

Barberi S, Bernardo L, Auria D, Ferrara F, Tosi S, Incorvaia C, et al. Allergen immunotherapy and respiratory infections in children: an encouraging experience. Minerva Pediatr 2015 Nov 25. 

Corresponding author e-mail

gio.cip@libero.it